Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The price of performance: a cost and performance analysis of the implementation of cell‐free fetal DNA testing for Down syndrome in Ontario, Canada

3 Jan 2014

Abstract excerpt

OBJECTIVE: To examine the cost and performance implications of introducing cell-free fetal DNA (cffDNA) testing within modeled scenarios in a publicly funded Canadian provincial Down syndrome (DS) prenatal screening program. METHOD: Two clinical algorithms were created: the first to represent the current screening program and the second to represent one that incorporates cffDNA testing. From these algorithms,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Ethics in Clinical Research
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24395030
DOI: 10.1002/pd.4311

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The price of performance: a cost and performance analysis of the implementation of cell‐free fetal DNA testing for Down syndrome in Ontario, CanadaPMID 24395030Read ↗

The price of abandoning diagnostic testing for cell‐free fetal DNA screeningSemantic proximity Read ↗

Cell‐free fetal <scp>DNA</scp> screening in the USA: a cost analysis of screening strategiesSemantic proximity Read ↗

Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategiesSemantic proximity Read ↗

A cost‐effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndromeSemantic proximity Read ↗

Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalitiesSemantic proximity Read ↗

Contingent screening for Down syndrome is an efficient alternative to non‐disclosure sequential screeningSemantic proximity Read ↗

Incorporating DNA Sequencing into Current Prenatal Screening Practice for Down's SyndromeSemantic proximity Read ↗

Nuchal translucency and first trimester biochemical markers for down syndrome screening: A cost-effectiveness analysisSemantic proximity Read ↗

Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in AustraliaSemantic proximity Read ↗

Trends in prenatal screening and diagnostic testing among women referred for advanced maternal ageSemantic proximity Read ↗

Rapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: the views of pregnant womenSemantic proximity Read ↗

Development, Testing, and Calibration of LINCS: A New Microsimulation Model of Maternal and Fetal Cytomegalovirus Infection in the USSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.